HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: jnumed.107.043919v1 49/9/1520    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Reshef, A. Articles by Ziv, I. PubMed PubMed Citation Articles by Reshef, A. Articles by Ziv, I.

Molecular Imaging of Neurovascular Cell Death in Experimental Cerebral Stroke by PET

¹ NST NeuroSurvival Technologies Ltd., Petach Tikva, Israel; ² Neurobiology and Imaging Program, Department of Biological Psychiatry, New York State Psychiatric Institute and Columbia University, New York, New York; ³ Albany Molecular Research, Albany, New York; and ⁴ Imanet, Uppsala, Sweden

Correspondence: For correspondence or reprints contact: Ayelet Reshef, NST NeuroSurvival Technologies Ltd., 5 Ha'Odem Street, P.O. Box 7119, Petach Tikva 49170, Israel. E-mail: ayelet{at}nst.co.il

Clinical molecular imaging of apoptosis is a highly desirable yet unmet challenge. Here we provide the first report on ¹⁸F-labeled 5-fluoropentyl-2-methyl-malonic acid (¹⁸F-ML-10), a small-molecule, ¹⁸F-labeled PET tracer for the imaging of apoptosis in vivo; this report includes descriptions of the synthesis, radiolabeling, and biodistribution of this novel apoptosis marker. We also describe the use of ¹⁸F-ML-10 for small-animal PET of neurovascular cell death in experimental cerebral stroke in mice. Methods: ¹⁸F-ML-10 was synthesized by nucleophilic substitution from the respective mesylate precursor, and its biodistribution was assessed in healthy rats. Permanent occlusion of the middle cerebral artery (MCA) was induced in mice, and small-animal PET was performed 24 h later. Results: Efficient radiolabeling of ML-10 with ¹⁸F was achieved. Biodistribution studies with ¹⁸F-ML-10 revealed rapid clearance from blood (half-life of 23 min), a lack of binding to healthy tissues, and rapid elimination through the kidneys. No significant tracer metabolism in vivo was observed. Clear images of distinct regions of increased uptake, selectively in the ischemic MCA territory, were obtained in the in vivo small-animal PET studies. Uptake measurements ex vivo revealed 2-fold-higher uptake in the affected hemisphere and 6- to 10-fold-higher uptake in the region of interest of the infarct. The cerebral uptake of ¹⁸F-ML-10 was well correlated with histologic evidence of cell death. The tracer was retained in the stroke area but was cleared from blood and from intact brain areas. Conclusion: ¹⁸F-ML-10 is useful for noninvasive PET of neurovascular histopathology in ischemic cerebral stroke in vivo. Such an assessment may assist in characterization of the extent of stroke-related cerebral damage and in the monitoring of disease course and effect of treatment.

Key Words: PET imaging • experimental stroke • apoptosis • middle cerebral artery occlusion

COPYRIGHT © 2008 by the Society of Nuclear Medicine, Inc.

Related articles in JNM:

This Month in JNM

JNM 2008 49: 11A-12A. [Full Text]